Data:
{
"symbol": "ARWR",
"price": 86.22,
"marketCap": 12144690540,
"beta": 1.265,
"lastDividend": 0,
"range": "15.01-95.49",
"change": 0.44,
"changePercentage": 0.51294,
"volume": 1771475,
"averageVolume": 2214068,
"companyName": "Arrowhead Pharmaceuticals, Inc.",
"currency": "USD",
"cik": "0000879407",
"isin": "US04280A1007",
"cusip": "04280A100",
"exchangeFullName": "NASDAQ Global Select",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://arrowheadpharma.com",
"description": "Arrowhead Pharmaceuticals, Inc., founded in 1989 and based in Pasadena, California, is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for complex and challenging-to-treat diseases within the United States. The company's extensive therapeutic pipeline primarily leverages RNA interference (RNAi) technology. Among its advanced clinical programs are: ARO-AAT, a Phase II therapeutic targeting liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is undergoing both Phase 2b and Phase 3 clinical evaluations for hypertriglyceridemia; ARO-ANG3, currently in Phase 2b development to reduce the production of angiopoietin-like protein 3; and ARO-HIF2, a Phase 1b candidate designed to treat clear cell renal cell carcinoma. Arrowhead also has several compounds in earlier clinical development, including ARO-HSD in Phase 1/2a for other liver diseases, ARO-ENaC in Phase 1/2a, aimed at decreasing the epithelial sodium channel alpha subunit in lung airways, and ARO-C3, also in Phase 1/2a, for complement-mediated diseases. Further expanding its diverse portfolio, the company is actively developing ARO-Lung2 for chronic obstructive pulmonary disorder (COPD), ARO-DUX4 for facioscapulohumeral muscular dystrophy, ARO-XDH for uncontrolled gout, and ARO-COV for COVID-19 and other pulmonary-borne pathogens. Beyond its core internal programs, Arrowhead is involved in the progression of JNJ-3989, a subcutaneously administered RNAi therapeutic for chronic hepatitis B virus infection; Olpasiran, intended to reduce apolipoprotein A production; and ARO-AMG1, which targets genetically validated cardiovascular pathways. Strategic collaborations are integral to Arrowhead's development efforts. The company holds a licensing and research agreement with Janssen Pharmaceuticals, Inc. for the co-development of ARO-JNJ1, ARO-JNJ2, and ARO-JNJ3, all RNAi therapeutics focused on liver-expressed targets. Additionally, Arrowhead has a licensing and research partnership with Takeda Pharmaceuticals U.S.A., Inc. to develop an RNAi therapeutic candidate specifically for liver disease.",
"ceo": "Christopher R. Anzalone",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "711",
"phone": "626 304 3400",
"address": "177 East Colorado Boulevard",
"city": "Pasadena",
"state": "CA",
"zip": "91105",
"image": "https://images.financialmodelingprep.com/symbol/ARWR.png",
"ipoDate": "1993-12-16",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false,
"sec_filings": [
{
"form": "SCHEDULE 13G/A",
"date": "2026-07-27",
"accession": "0002012383-26-002186",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000201238326002186/xslSCHEDULE_13G_X02/primary_doc.xml"
},
{
"form": "4",
"date": "2026-06-17",
"accession": "0002141314-26-000004",
"description": "FORM 4",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000214131426000004/xslF345X06/wk-form4_1781747052.xml"
},
{
"form": "3",
"date": "2026-06-17",
"accession": "0002141314-26-000003",
"description": "FORM 3",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000214131426000003/xslF345X06/wk-form3_1781747046.xml"
},
{
"form": "8-K",
"date": "2026-06-16",
"accession": "0000879407-26-000050",
"description": "8-K",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000087940726000050/arwr-20260612.htm"
},
{
"form": "144/A",
"date": "2026-05-19",
"accession": "0001628280-26-036528",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000162828026036528/xsl144X01/primary_doc.xml"
},
{
"form": "144/A",
"date": "2026-05-19",
"accession": "0001628280-26-036522",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000162828026036522/xsl144X01/primary_doc.xml"
},
{
"form": "144/A",
"date": "2026-05-19",
"accession": "0001628280-26-036511",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000162828026036511/xsl144X01/primary_doc.xml"
},
{
"form": "4",
"date": "2026-05-14",
"accession": "0001767584-26-000002",
"description": "FORM 4",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000176758426000002/xslF345X06/wk-form4_1778799941.xml"
},
{
"form": "144",
"date": "2026-05-12",
"accession": "0001628280-26-034153",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000162828026034153/xsl144X01/primary_doc.xml"
},
{
"form": "S-8",
"date": "2026-05-07",
"accession": "0001193125-26-212473",
"description": "S-8",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000119312526212473/d30467ds8.htm"
},
{
"form": "10-Q",
"date": "2026-05-07",
"accession": "0000879407-26-000047",
"description": "10-Q",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000087940726000047/arwr-20260331.htm"
},
{
"form": "8-K",
"date": "2026-05-07",
"accession": "0000879407-26-000045",
"description": "8-K",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000087940726000045/arwr-20260507.htm"
},
{
"form": "SCHEDULE 13G",
"date": "2026-05-06",
"accession": "0000315066-26-001120",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000031506626001120/xslSCHEDULE_13G_X02/primary_doc.xml"
},
{
"form": "SCHEDULE 13G",
"date": "2026-04-29",
"accession": "0002100119-26-000162",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000210011926000162/xslSCHEDULE_13G_X02/primary_doc.xml"
},
{
"form": "SCHEDULE 13G",
"date": "2026-04-28",
"accession": "0002100121-26-000087",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000210012126000087/xslSCHEDULE_13G_X02/primary_doc.xml"
}
]
}
Data:
{
"symbol": "ARWR",
"name": "Arrowhead Pharmaceuticals, Inc.",
"price": 86.22,
"changePercentage": 0.51294,
"change": 0.44,
"volume": 1771475,
"dayLow": 84.34,
"dayHigh": 87.89,
"yearHigh": 95.49,
"yearLow": 15.01,
"marketCap": 12144690540,
"priceAvg50": 78.2777,
"priceAvg200": 64.68605,
"exchange": "NASDAQ",
"open": 85.56,
"previousClose": 85.78,
"timestamp": 1785355201
}
Data:
{
"volume": 1771475,
"avgVolume": 2214068,
"short_ratio": [
{
"symbol": "ARWR",
"file_date": "2026-07-29",
"date": "20260729",
"short_volume": 478258,
"short_exempt_volume": 1242,
"total_volume": 725091,
"short_volume_ratio": 0.6596,
"signal": "Bearish"
}
],
"volume_profile": {
"poc": 86.35,
"vah": 94.79,
"val": 74.21,
"profile": [
{
"price": 70.3,
"volume": 630558
},
{
"price": 70.71,
"volume": 960476
},
{
"price": 71.12,
"volume": 595498
},
{
"price": 71.53,
"volume": 1468281
},
{
"price": 71.94,
"volume": 700793
},
{
"price": 72.36,
"volume": 964095
},
{
"price": 72.77,
"volume": 1162934
},
{
"price": 73.18,
"volume": 1400477
},
{
"price": 73.59,
"volume": 1330808
},
{
"price": 74.0,
"volume": 1988314
},
{
"price": 74.41,
"volume": 1380365
},
{
"price": 74.83,
"volume": 103591
},
{
"price": 75.24,
"volume": 0
},
{
"price": 75.65,
"volume": 0
},
{
"price": 76.06,
"volume": 0
},
{
"price": 76.47,
"volume": 635703
},
{
"price": 76.88,
"volume": 729099
},
{
"price": 77.29,
"volume": 322207
},
{
"price": 77.71,
"volume": 385757
},
{
"price": 78.12,
"volume": 257900
},
{
"price": 78.53,
"volume": 42851
},
{
"price": 78.94,
"volume": 28384
},
{
"price": 79.35,
"volume": 50067
},
{
"price": 79.76,
"volume": 149631
},
{
"price": 80.18,
"volume": 65251
},
{
"price": 80.59,
"volume": 28907
},
{
"price": 81.0,
"volume": 76874
},
{
"price": 81.41,
"volume": 105294
},
{
"price": 81.82,
"volume": 138045
},
{
"price": 82.23,
"volume": 149512
},
{
"price": 82.64,
"volume": 328379
},
{
"price": 83.06,
"volume": 231995
},
{
"price": 83.47,
"volume": 517216
},
{
"price": 83.88,
"volume": 981237
},
{
"price": 84.29,
"volume": 389656
},
{
"price": 84.7,
"volume": 988418
},
{
"price": 85.11,
"volume": 797202
},
{
"price": 85.53,
"volume": 1971523
},
{
"price": 85.94,
"volume": 2033603
},
{
"price": 86.35,
"volume": 2588298
},
{
"price": 86.76,
"volume": 2032164
},
{
"price": 87.17,
"volume": 1959303
},
{
"price": 87.58,
"volume": 539958
},
{
"price": 87.99,
"volume": 481367
},
{
"price": 88.41,
"volume": 218770
},
{
"price": 88.82,
"volume": 410175
},
{
"price": 89.23,
"volume": 813856
},
{
"price": 89.64,
"volume": 384623
},
{
"price": 90.05,
"volume": 771326
},
{
"price": 90.46,
"volume": 414946
},
{
"price": 90.88,
"volume": 828885
},
{
"price": 91.29,
"volume": 373104
},
{
"price": 91.7,
"volume": 544998
},
{
"price": 92.11,
"volume": 219546
},
{
"price": 92.52,
"volume": 241374
},
{
"price": 92.93,
"volume": 217969
},
{
"price": 93.34,
"volume": 78600
},
{
"price": 93.76,
"volume": 0
},
{
"price": 94.17,
"volume": 162777
},
{
"price": 94.58,
"volume": 138859
}
],
"sessions": 20
}
}
Data:
{
"symbol": "ARWR",
"marketCap": 12144690540,
"enterpriseValueTTM": 13329461540,
"evToSalesTTM": 21.429692399949197,
"evToOperatingCashFlowTTM": -367.14211259846854,
"evToFreeCashFlowTTM": -262.01960882214183,
"evToEBITDATTM": -99.12738748252373,
"netDebtToEBITDATTM": -8.810802570128208,
"currentRatioTTM": 6.231796626244835,
"incomeQualityTTM": 0.13596683406923052,
"grahamNumberTTM": null,
"grahamNetNetTTM": 0.8882770315341567,
"taxBurdenTTM": 1.192855047529949,
"interestBurdenTTM": 1.5782650858698033,
"workingCapitalTTM": 1544531000,
"investedCapitalTTM": 1968158000,
"returnOnAssetsTTM": -0.13266174807617276,
"operatingReturnOnAssetsTTM": -0.11460198541180432,
"returnOnTangibleAssetsTTM": -0.13301424154847333,
"returnOnEquityTTM": -0.5544812794020907,
"returnOnInvestedCapitalTTM": -0.1098044902140194,
"returnOnCapitalEmployedTTM": -0.11246322308918448,
"earningsYieldTTM": -0.024505843491968556,
"freeCashFlowYieldTTM": -0.004188826370869389,
"capexToOperatingCashFlowTTM": -0.40120090343193965,
"capexToDepreciationTTM": 0.5597141100522595,
"capexToRevenueTTM": 0.023417667590018794,
"salesGeneralAndAdministrativeToRevenueTTM": 0.2481973733499033,
"researchAndDevelopementToRevenueTTM": 1.1053071579350138,
"stockBasedCompensationToRevenueTTM": 0.10982960053632665,
"intangiblesToTotalAssetsTTM": 0.002650043094611961,
"averageReceivablesTTM": 117278000,
"averagePayablesTTM": 31842000,
"averageInventoryTTM": 0,
"daysOfSalesOutstandingTTM": 9.204087079125864,
"daysOfPayablesOutstandingTTM": 0,
"daysOfInventoryOutstandingTTM": 0,
"operatingCycleTTM": 9.204087079125864,
"cashConversionCycleTTM": 9.204087079125864,
"freeCashFlowToEquityTTM": 506166000,
"freeCashFlowToFirmTTM": 48735934.00115752,
"tangibleAssetValueTTM": 592905000,
"netCurrentAssetValueTTM": 170402000,
"grossProfitMarginTTM": 1,
"ebitMarginTTM": -0.25696573522248073,
"ebitdaMarginTTM": -0.21618336712169758,
"operatingProfitMarginTTM": -0.3567392111689702,
"pretaxProfitMarginTTM": -0.40556004816650565,
"continuousOperationsProfitMarginTTM": -0.4370692385479953,
"netProfitMarginTTM": -0.4837743505319055,
"bottomLineProfitMarginTTM": -0.4837743505319055,
"receivablesTurnoverTTM": 39.6562958240357,
"payablesTurnoverTTM": 0,
"inventoryTurnoverTTM": 0,
"fixedAssetTurnoverTTM": 1.4894280870464733,
"assetTurnoverTTM": 0.2742223681977194,
"quickRatioTTM": 6.231796626244835,
"solvencyRatioTTM": -0.1650613502628869,
"cashRatioTTM": 0.6385644604024118,
"priceToEarningsRatioTTM": -40.28971962616822,
"priceToEarningsGrowthRatioTTM": 0.0033232320963796805,
"forwardPriceToEarningsGrowthRatioTTM": -1.0187808544034764,
"priceToBookRatioTTM": 19.99943603750629,
"priceToSalesRatioTTM": 19.52494343329437,
"priceToFreeCashFlowRatioTTM": -238.73035343607484,
"priceToOperatingCashFlowRatioTTM": -338.21389687654937,
"debtToAssetsRatioTTM": 0.6054354319270455,
"debtToEquityRatioTTM": 2.2367091926896285,
"debtToCapitalRatioTTM": 0.6910442240969372,
"longTermDebtToCapitalRatioTTM": 0.6662052805693207,
"financialLeverageRatioTTM": 3.694381059876836,
"workingCapitalTurnoverRatioTTM": 0.5245712093004624,
"operatingCashFlowRatioTTM": -0.12297947293543798,
"operatingCashFlowSalesRatioTTM": -0.05836893035309779,
"freeCashFlowOperatingCashFlowRatioTTM": 1.4012009034319397,
"debtServiceCoverageRatioTTM": -1.0989008637598876,
"interestCoverageRatioTTM": -2.4007595183225683,
"shortTermOperatingCashFlowCoverageRatioTTM": -0.7599531125716917,
"operatingCashFlowCoverageRatioTTM": -0.026437280453917897,
"capitalExpenditureCoverageRatioTTM": -2.492516819991762,
"dividendPaidAndCapexCoverageRatioTTM": -2.492516819991762,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 4.36751932704663,
"netIncomePerShareTTM": -2.1128938258775287,
"interestDebtPerShareTTM": 10.291713770125757,
"cashPerShareTTM": 12.52723340612427,
"bookValuePerShareTTM": 4.205368741091302,
"tangibleBookValuePerShareTTM": 4.1631617012014015,
"shareholdersEquityPerShareTTM": 4.31112156554344,
"operatingCashFlowPerShareTTM": -0.2549274314161933,
"capexPerShareTTM": 0.10227711579376057,
"freeCashFlowPerShareTTM": -0.35720454720995387,
"netIncomePerEBTTTM": 1.192855047529949,
"ebtPerEbitTTM": 1.1368530160661574,
"priceToFairValueTTM": 19.99943603750629,
"debtToMarketCapTTM": 0.10483445385509181,
"effectiveTaxRateTTM": -0.07769303343349375,
"enterpriseValueMultipleTTM": -99.12738748252373,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 829448000
}
],
"dcf": {
"symbol": "ARWR",
"date": "2026-07-30",
"dcf": -98.62379638860037,
"Stock Price": 86.22
},
"statements": {
"income": [
{
"date": "2025-09-30",
"symbol": "ARWR",
"reportedCurrency": "USD",
"cik": "0000879407",
"filingDate": "2025-11-25",
"acceptedDate": "2025-11-25 16:13:58",
"fiscalYear": "2025",
"period": "FY",
"revenue": 829448000,
"costOfRevenue": 0,
"grossProfit": 829448000,
"researchAndDevelopmentExpenses": 607159000,
"generalAndAdministrativeExpenses": 121915000,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 121915000,
"otherExpenses": 2028000,
"operatingExpenses": 731102000,
"costAndExpenses": 731102000,
"netInterestIncome": -52072000,
"interestIncome": 37289000,
"interestExpense": 89361000,
"depreciationAndAmortization": 23928000,
"ebitda": 164822000,
"ebit": 140894000,
"nonOperatingIncomeExcludingInterest": -42548000,
"operatingIncome": 98346000,
"totalOtherIncomeExpensesNet": -46813000,
"incomeBeforeTax": 51533000,
"incomeTaxExpense": 21419000,
"netIncomeFromContinuingOperations": 30114000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -1631000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -1631000,
"eps": -0.0122,
"epsDiluted": -0.0122,
"weightedAverageShsOut": 133758000,
"weightedAverageShsOutDil": 133758000
}
],
"balance_sheet": [
{
"date": "2025-09-30",
"symbol": "ARWR",
"reportedCurrency": "USD",
"cik": "0000879407",
"filingDate": "2025-11-25",
"acceptedDate": "2025-11-25 16:13:58",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 226548000,
"shortTermInvestments": 692818000,
"cashAndShortTermInvestments": 919366000,
"netReceivables": 6824000,
"accountsReceivables": 6824000,
"otherReceivables": 0,
"inventory": 0,
"prepaids": 10933000,
"otherCurrentAssets": 13516000,
"totalCurrentAssets": 950639000,
"propertyPlantEquipmentNet": 426406000,
"goodwill": 0,
"intangibleAssets": 6861000,
"goodwillAndIntangibleAssets": 6861000,
"longTermInvestments": 0,
"taxAssets": 0,
"otherNonCurrentAssets": 1389000,
"totalNonCurrentAssets": 434656000,
"otherAssets": 0,
"totalAssets": 1385295000,
"totalPayables": 38473000,
"accountPayables": 17674000,
"otherPayables": 20799000,
"accruedExpenses": 26895000,
"shortTermDebt": 40000000,
"capitalLeaseObligationsCurrent": 7289000,
"taxPayables": 0,
"deferredRevenue": 2399000,
"otherCurrentLiabilities": 80431000,
"totalCurrentLiabilities": 195487000,
"longTermDebt": 214883000,
"capitalLeaseObligationsNonCurrent": 104112000,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 367397000,
"totalNonCurrentLiabilities": 686392000,
"otherLiabilities": 0,
"capitalLeaseObligations": 111401000,
"totalLiabilities": 881879000,
"treasuryStock": -53193000,
"preferredStock": 0,
"commonStock": 231000,
"retainedEarnings": -1627154000,
"additionalPaidInCapital": 2139725000,
"accumulatedOtherComprehensiveIncomeLoss": 6443000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 466052000,
"totalEquity": 503416000,
"minorityInterest": 37364000,
"totalLiabilitiesAndTotalEquity": 1385295000,
"totalInvestments": 692818000,
"totalDebt": 366284000,
"netDebt": 139736000
}
],
"cash_flow": [
{
"date": "2025-09-30",
"symbol": "ARWR",
"reportedCurrency": "USD",
"cik": "0000879407",
"filingDate": "2025-11-25",
"acceptedDate": "2025-11-25 16:13:58",
"fiscalYear": "2025",
"period": "FY",
"netIncome": 30114000,
"depreciationAndAmortization": 23928000,
"deferredIncomeTax": 0,
"stockBasedCompensation": 63366000,
"changeInWorkingCapital": -18235000,
"accountsReceivables": -56967000,
"inventory": 0,
"accountsPayables": 6286000,
"otherWorkingCapital": 32446000,
"otherNonCashItems": 80379000,
"netCashProvidedByOperatingActivities": 179552000,
"investmentsInPropertyPlantAndEquipment": -22666000,
"acquisitionsNet": 0,
"purchasesOfInvestments": -796258000,
"salesMaturitiesOfInvestments": 689630000,
"otherInvestingActivities": 0,
"netCashProvidedByInvestingActivities": -129294000,
"netDebtIssuance": -191365000,
"longTermNetDebtIssuance": -201625000,
"shortTermNetDebtIssuance": 10260000,
"netStockIssuance": 270371000,
"netCommonStockIssuance": 270371000,
"commonStockIssuance": 270371000,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -5000000,
"netCashProvidedByFinancingActivities": 74006000,
"effectOfForexChangesOnCash": -401000,
"netChangeInCash": 123863000,
"cashAtEndOfPeriod": 226548000,
"cashAtBeginningOfPeriod": 102685000,
"operatingCashFlow": 179552000,
"capitalExpenditure": -22666000,
"freeCashFlow": 156886000,
"incomeTaxesPaid": 0,
"interestPaid": 19000
}
]
}
}
Data:
{
"price": 86.22,
"rsi": 60.23861006150672,
"sma20": 80.6195,
"sma50": 78.27779999999998,
"sma200": 64.68614999999998,
"adx": 27.110982926588967,
"atr": 4.98,
"atr_pct": 5.78,
"high_52w": 88.7,
"low_52w": 9.99,
"structure": {
"ema8": 83.61171464551255,
"ema21": 80.95596724221248,
"ema50": 78.23348494937588,
"ema200": 63.82818561748714,
"checks": {
"price_above_all": true,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": true,
"adx_over_30": false,
"higher_highs_lows": true,
"near_21ema": true
},
"dist_21ema_pct": 6.5,
"macd": {
"macd": 1.936,
"signal": 0.946,
"histogram": 0.99
},
"bollinger": {
"mid": 80.62,
"upper": 93.2,
"lower": 68.04,
"width_pct": 31.21
},
"crossover": {
"fresh_cross": true,
"pre_compressed": true,
"held_above_21": true,
"candles_since": 4,
"intraday_support": false
},
"momentum": {
"roc10": 20.1,
"checks": {
"roc_over_5": true,
"rsi_in_band": true,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": true
},
"volume": {
"rvol": 0.76,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": false
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 5.95,
"checks": {
"beats_spy_all": false,
"beats_sector_10d": true,
"rs_line_at_high": false,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"avg_vol_over_2m": true,
"mcap_over_1b": true,
"no_earnings_7d": false,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": true
},
"avg_dollar_vol": 190896942.96,
"avg_vol": 2214068
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.4,
"iv_rank": 20.0
}
}
}
}
Data:
{
"prior_day": {
"high": 87.89,
"low": 84.34,
"close": 86.22,
"date": "2026-07-29"
},
"woodie_pivots": {
"PP": 86.17,
"R1": 88.0,
"S1": 84.45,
"R2": 89.72,
"S2": 82.62
},
"swing": {
"high_20d": 95.49,
"low_20d": 69.88,
"high_60d": 95.49,
"low_60d": 69.3
},
"volume_profile": {
"poc": 86.35,
"vah": 94.79,
"val": 74.21,
"sessions": 20
},
"recent_daily": [
{
"d": "2026-06-24",
"o": 80.72,
"h": 82.84,
"l": 79.31,
"c": 79.81,
"v": 2048098.410422
},
{
"d": "2026-06-25",
"o": 79.65,
"h": 83.42,
"l": 78.055,
"c": 79.27,
"v": 2430003.740169
},
{
"d": "2026-06-26",
"o": 78.94,
"h": 82.295,
"l": 77.45,
"c": 78.89,
"v": 18919782.477948
},
{
"d": "2026-06-29",
"o": 79.79,
"h": 80.59,
"l": 78.17,
"c": 80.5,
"v": 1656577.590847
},
{
"d": "2026-06-30",
"o": 80.52,
"h": 84.055,
"l": 78.865,
"c": 81.51,
"v": 2715683.782064
},
{
"d": "2026-07-01",
"o": 82.28,
"h": 82.385,
"l": 78.81,
"c": 80.44,
"v": 1975606.536537
},
{
"d": "2026-07-02",
"o": 81.14,
"h": 83.99,
"l": 79.915,
"c": 83.99,
"v": 1703383.94912
},
{
"d": "2026-07-06",
"o": 84.59,
"h": 87.83,
"l": 83.13,
"c": 86.55,
"v": 2445846.930226
},
{
"d": "2026-07-07",
"o": 87.275,
"h": 87.57,
"l": 83.79,
"c": 86.97,
"v": 1914966.461587
},
{
"d": "2026-07-08",
"o": 85.87,
"h": 86.8629,
"l": 84.19,
"c": 85.74,
"v": 1660445.25484
},
{
"d": "2026-07-09",
"o": 86.12,
"h": 87.73,
"l": 83.3015,
"c": 84,
"v": 1437721.543189
},
{
"d": "2026-07-10",
"o": 84.48,
"h": 84.48,
"l": 76.18,
"c": 76.4,
"v": 2952941.53265
},
{
"d": "2026-07-13",
"o": 74.82,
"h": 74.89,
"l": 72.66,
"c": 74.11,
"v": 2481815.270297
},
{
"d": "2026-07-14",
"o": 74.42,
"h": 75.325,
"l": 71.81,
"c": 71.91,
"v": 1635673.697598
},
{
"d": "2026-07-15",
"o": 71.91,
"h": 72.67,
"l": 69.88,
"c": 71.82,
"v": 1863848.809723
},
{
"d": "2026-07-16",
"o": 70.92,
"h": 73,
"l": 69.95,
"c": 71.375,
"v": 2578672.812623
},
{
"d": "2026-07-17",
"o": 70.92,
"h": 74.8,
"l": 70.01,
"c": 74.3,
"v": 3775226.021734
},
{
"d": "2026-07-20",
"o": 74.35,
"h": 75.06,
"l": 71,
"c": 71.65,
"v": 2410748.643491
},
{
"d": "2026-07-21",
"o": 72.81,
"h": 74.7,
"l": 72.62,
"c": 74.52,
"v": 1612496.635536
},
{
"d": "2026-07-22",
"o": 85.46,
"h": 95.4899,
"l": 84.34,
"c": 88.7,
"v": 6990867.283622
},
{
"d": "2026-07-23",
"o": 88.72,
"h": 89.15,
"l": 86.26,
"c": 86.78,
"v": 2479807.294155
},
{
"d": "2026-07-24",
"o": 86.84,
"h": 87.5,
"l": 85.06,
"c": 85.6,
"v": 1825246.749704
},
{
"d": "2026-07-27",
"o": 85.77,
"h": 87.93,
"l": 85.21,
"c": 85.53,
"v": 2444316.353809
},
{
"d": "2026-07-28",
"o": 86.31,
"h": 86.64,
"l": 82.77,
"c": 85.78,
"v": 1694969.346481
},
{
"d": "2026-07-29",
"o": 85.56,
"h": 87.89,
"l": 84.34,
"c": 86.22,
"v": 1808776.75966
}
]
}
Data:
{
"estimates": [
{
"symbol": "ARWR",
"date": "2030-09-30",
"revenueLow": 1073447162,
"revenueHigh": 2770522719,
"revenueAvg": 1764840000,
"ebitdaLow": -1749285931,
"ebitdaHigh": -677765970,
"ebitdaAvg": -1114305889,
"ebitLow": -1840637745,
"ebitHigh": -713160498,
"ebitAvg": -1172497556,
"netIncomeLow": 207674009,
"netIncomeHigh": 736723018,
"netIncomeAvg": 423210315,
"sgaExpenseLow": 6201829216,
"sgaExpenseHigh": 16006664652,
"sgaExpenseAvg": 10196343762,
"epsAvg": 3.164,
"epsHigh": 5.50788,
"epsLow": 1.55261,
"numAnalystsRevenue": 4,
"numAnalystsEps": 5
},
{
"symbol": "ARWR",
"date": "2029-09-30",
"revenueLow": 560907223,
"revenueHigh": 1447678339,
"revenueAvg": 922180000,
"ebitdaLow": -914052548,
"ebitdaHigh": -354152343,
"ebitdaAvg": -582257091,
"ebitLow": -961786516,
"ebitHigh": -372647009,
"ebitAvg": -612663922,
"netIncomeLow": -367430553,
"netIncomeHigh": -103574170,
"netIncomeAvg": -211070125,
"sgaExpenseLow": 3240635334,
"sgaExpenseHigh": 8363945741,
"sgaExpenseAvg": 5327884845,
"epsAvg": -1.578,
"epsHigh": -0.77434,
"epsLow": -2.74698,
"numAnalystsRevenue": 4,
"numAnalystsEps": 2
},
{
"symbol": "ARWR",
"date": "2028-09-30",
"revenueLow": 341483520,
"revenueHigh": 1104966634,
"revenueAvg": 645157452,
"ebitdaLow": -697667113,
"ebitdaHigh": -215609968,
"ebitdaAvg": -407347265,
"ebitLow": -734100926,
"ebitHigh": -226869627,
"ebitAvg": -428619895,
"netIncomeLow": -676078478,
"netIncomeHigh": 94768881,
"netIncomeAvg": -462194810,
"sgaExpenseLow": 1972917295,
"sgaExpenseHigh": 6383932620,
"sgaExpenseAvg": 3727390109,
"epsAvg": -2.76,
"epsHigh": 0.70851,
"epsLow": -5.05449,
"numAnalystsRevenue": 8,
"numAnalystsEps": 7
},
{
"symbol": "ARWR",
"date": "2027-09-30",
"revenueLow": 119041150,
"revenueHigh": 579609724,
"revenueAvg": 326984768,
"ebitdaLow": -365960953,
"ebitdaHigh": -75161631,
"ebitdaAvg": -206455572,
"ebitLow": -385072292,
"ebitHigh": -79086748,
"ebitAvg": -217237166,
"netIncomeLow": -931011865,
"netIncomeHigh": -280693840,
"netIncomeAvg": -661716930,
"sgaExpenseLow": 687758939,
"sgaExpenseHigh": 3348688829,
"sgaExpenseAvg": 1889150914,
"epsAvg": -4.37364,
"epsHigh": -2.09852,
"epsLow": -6.96042,
"numAnalystsRevenue": 10,
"numAnalystsEps": 10
}
],
"price_target": {
"symbol": "ARWR",
"targetHigh": 126,
"targetLow": 46,
"targetConsensus": 103.33,
"targetMedian": 115
},
"ratings": {
"symbol": "ARWR",
"rating": "D+",
"overallScore": 1,
"discountedCashFlowScore": 1,
"returnOnEquityScore": 1,
"returnOnAssetsScore": 1,
"debtToEquityScore": 1,
"priceToEarningsScore": 1,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "ARWR",
"date": "2026-07-27",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2026-07-23",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2026-07-23",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2026-07-22",
"gradingCompany": "Chardan Capital",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2026-07-17",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2026-07-01",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2026-06-30",
"gradingCompany": "Chardan Capital",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2026-06-17",
"gradingCompany": "Leerink Partners",
"previousGrade": "Market Perform",
"newGrade": "Market Perform",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2026-05-13",
"gradingCompany": "Bernstein",
"previousGrade": "Market Perform",
"newGrade": "Market Perform",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2026-05-08",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2026-04-21",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Overweight",
"action": "upgrade"
},
{
"symbol": "ARWR",
"date": "2026-03-25",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2026-02-10",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2026-01-22",
"gradingCompany": "B. Riley Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2026-01-21",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2026-01-13",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2026-01-07",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2026-01-07",
"gradingCompany": "Goldman Sachs",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2026-01-07",
"gradingCompany": "Chardan Capital",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2025-12-17",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2025-12-11",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2025-12-09",
"gradingCompany": "B of A Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2025-12-02",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2025-12-01",
"gradingCompany": "B of A Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2025-12-01",
"gradingCompany": "Chardan Capital",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2025-11-26",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2025-11-20",
"gradingCompany": "Goldman Sachs",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2025-11-19",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2025-11-19",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2025-11-19",
"gradingCompany": "Chardan Capital",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2025-11-12",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2025-10-08",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2025-09-02",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2025-08-11",
"gradingCompany": "Chardan Capital",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARWR",
"date": "2025-08-08",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
}
]
}
Data:
[
{
"title": "H.C. Wainwright raises Arrowhead Pharma price target to $115 on trial data By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/hc-wainwright-raises-arrowhead-pharma-price-target-to-115-on-trial-data-93CH-4813792",
"source": "Investing.com",
"date": "2026-07-27T11:38:54Z",
"summary": "Investing.com - H.C. Wainwright raised its price target on Arrowhead Pharmaceuticals stock (NASDAQ:ARWR) to $115 from $100 while maintaining a Buy rating. The stock has surged 444% over the past year to $85.60, though InvestingPro data suggests shares are currently trading above "
},
{
"title": "Arrowhead Pharmaceuticals Completes Enrollment in Global Phase 3 YOSEMITE Study of Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia",
"url": "https://www.gurufocus.com/news/8980199/arrowhead-pharmaceuticals-completes-enrollment-in-global-phase-3-yosemite-study-of-zodasiran-for-the-treatment-of-homozygous-familial-hypercholesterolemia",
"source": "GuruFocus",
"date": "2026-07-27 08:00:00",
"summary": "[url=\"]Arrowhead Pharmaceuticals, Inc.[/url] (NASDAQ: ARWR) today announced that it has completed enrollment in the global Phase 3 YOSEMITE clinical trial of z"
},
{
"title": "Arrowhead Pharmaceuticals, Inc. $ARWR Shares Purchased by Affinity Asset Advisors LLC",
"url": "https://www.defenseworld.net/2026/07/25/arrowhead-pharmaceuticals-inc-arwr-shares-purchased-by-affinity-asset-advisors-llc.html",
"source": "Defense World",
"date": "2026-07-25 04:05:33",
"summary": "Affinity Asset Advisors LLC lifted its stake in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) by 185.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 200,000 shares of the biotechnolo"
},
{
"title": "California Public Employees Retirement System Makes New Investment in Arrowhead Pharmaceuticals, Inc. $ARWR",
"url": "https://www.defenseworld.net/2026/07/24/california-public-employees-retirement-system-makes-new-investment-in-arrowhead-pharmaceuticals-inc-arwr.html",
"source": "Defense World",
"date": "2026-07-24 04:43:23",
"summary": "California Public Employees Retirement System purchased a new position in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 257,133 "
},
{
"title": "Is Arrowhead Pharmaceuticals Stock A Smart Buy After Its Transition To A Commercial Company?",
"url": "https://finance.yahoo.com/markets/stocks/articles/arrowhead-pharmaceuticals-stock-smart-buy-150056575.html",
"source": "Yahoo! Finance",
"date": "2026-07-23T15:00:56Z",
"summary": "With its first drug on the market and a pipeline full of catalysts, the company asks investors to weigh a powerful growth story against an elevated valuation and a history of volatility.\n\nArrowhead Pharmaceuticals (ARWR) is no longer just a story stock about the promise of its sc"
},
{
"title": "Arrowhead (ARWR) Soars to New High as Plozasiran Nears Expanded Commercialization",
"url": "https://finance.yahoo.com/healthcare/articles/arrowhead-arwr-soars-high-plozasiran-190548574.html",
"source": "Yahoo! Finance",
"date": "2026-07-22T19:05:48Z",
"summary": "Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) skyrocketed to a five-year high on Wednesday, as investors began positioning portfolios ahead of the supplemental new drug application (sNDA) of its drug candidate, plozasiran, for the treatment of severe hypertriglyceridemia.\n\nIn intr"
},
{
"title": "Palantir, Philip Morris among market cap stock movers on Wednesday By Investing.com",
"url": "https://www.investing.com/news/stock-market-news/palantir-philip-morris-among-market-cap-stock-movers-on-wednesday-93CH-4806400",
"source": "Investing.com",
"date": "2026-07-22T14:35:39Z",
"summary": "Wednesday's market has seen swings in various stocks based on news and other factors. Today, stocks like Philip Morris and Arrowhead Research are rallying, while stocks like Palantir Technologies and Reddit are falling. Below are highlights of some of the biggest stock movers, fr"
},
{
"title": "Arrowhead Pharmaceuticals shares surge after positive Phase 3 results for plozasiran (NASDAQ:ARWR)",
"url": "https://finance.yahoo.com/healthcare/articles/arrowhead-pharmaceuticals-shares-surge-positive-122307897.html",
"source": "Yahoo! Finance",
"date": "2026-07-22T12:23:07Z",
"summary": "Late-stage studies achieve all primary and secondary goals\n\nArrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) shares jumped 18% on Wednesday after the company announced positive topline data from its Phase 3 SHASTA-3 and SHASTA-4 clinical trials evaluating plozasiran in patients with "
},
{
"title": "Arrowhead Pharmaceuticals stock jumps on Phase 3 trial results By Investing.com",
"url": "https://www.investing.com/news/stock-market-news/arrowhead-pharmaceuticals-stock-jumps-on-phase-3-trial-results-93CH-4805645",
"source": "Investing.com",
"date": "2026-07-22T11:54:44Z",
"summary": "Investing.com -- Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) shares rose 18% Wednesday following the announcement of topline results from its Phase 3 SHASTA-3 and SHASTA-4 studies of plozasiran in patients with severe hypertriglyceridemia.\n\nThe studies met their primary endpoint"
},
{
"title": "Arrowhead Pharmaceuticals (ARWR) Stock Looks Fairly Priced With Strong Sales But A Demanding 398% Run",
"url": "https://finance.yahoo.com/markets/stocks/articles/arrowhead-pharmaceuticals-arwr-stock-looks-111039015.html",
"source": "Yahoo! Finance",
"date": "2026-07-22T11:10:39Z",
"summary": "Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE.\n\nAfter a sharp 398.1% gain over the past year, Arrowhead Pharmaceuticals no longer looks obviously cheap, with its current valuation checks pointing to a more balanc"
},
{
"title": "Arrowhead Drug Shows Strong Efficacy In Cutting Blood Fat",
"url": "https://www.benzinga.com/news/health-care/26/07/60619285/arrowhead-drug-shows-strong-efficacy-in-cutting-blood-fat",
"source": "Benzinga",
"date": "2026-07-22 14:25:17",
"summary": "Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) stock is trading higher on Wednesday as the company revealed successful topline outcomes from its late-stage SHASTA-3 and SHASTA-4 trials evaluating plozasiran in individuals suffering from severe hypertriglyceridemia."
},
{
"title": "Arrowhead: Stock Up On SHTG Data - No Ceiling On Valuation Growth Potential",
"url": "https://seekingalpha.com/article/4924293-arrowhead-stock-up-on-shtg-data-no-ceiling-on-valuation-growth-potential",
"source": "Seeking Alpha",
"date": "2026-07-22 13:28:45",
"summary": "Arrowhead Pharmaceuticals surged nearly 20% after strong Phase 3 results for plozasiran in severe hypertriglyceridemia, showing 79\u201381% triglyceride reductions and significant acute pancreatitis risk reduction. Plozasiran's quarterly dosing, robust efficacy, and favorable safety p"
},
{
"title": "Arrowhead Pharmaceuticals: Redemplo Meets High Expectations In SHTG Trials",
"url": "https://seekingalpha.com/article/4924159-arrowhead-pharmaceuticals-redemplo-meets-high-expectations-in-shtg-trials",
"source": "Seeking Alpha",
"date": "2026-07-22 10:24:46",
"summary": "Arrowhead Pharmaceuticals reported positive phase 3 results for Redemplo, achieving 79-81% triglyceride reductions and significant acute pancreatitis risk reduction in severe hypertriglyceridemia. Redemplo demonstrates strong efficacy, quarterly dosing, and a favorable safety pro"
},
{
"title": "Arrowhead Pharmaceuticals Reports Topline Results from Phase 3 SHASTA-3 and SHASTA-4 Studies of Plozasiran in Patients with Severe Hypertriglyceridemia",
"url": "https://www.gurufocus.com/news/8971436/arrowhead-pharmaceuticals-reports-topline-results-from-phase-3-shasta3-and-shasta4-studies-of-plozasiran-in-patients-with-severe-hypertriglyceridemia",
"source": "GuruFocus",
"date": "2026-07-22 08:00:00",
"summary": "[url=\"]Arrowhead Pharmaceuticals, Inc.[/url] (NASDAQ: ARWR) today announced topline results for the global Phase 3 SHASTA-3 and SHASTA-4 clinical studies of pl"
},
{
"title": "These major drug stocks rally after Trump's zero tariff announcement",
"url": "https://finbold.com/these-major-drug-stocks-rally-after-trumps-zero-tariff-announcement/",
"source": "Finbold",
"date": "2026-07-22 06:31:14",
"summary": "President Donald Trump has announced that all generic drugs imported into the United States would continue to enjoy a zero-percent tariff for another two years, sending major drug stocks up."
},
{
"title": "Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Third Quarter Results",
"url": "https://www.businesswire.com/news/home/20260721983600/en/Arrowhead-Pharmaceuticals-to-Webcast-Fiscal-2026-Third-Quarter-Results/",
"source": "Business Wire",
"date": "2026-07-21 07:30:00",
"summary": "PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on August 4, 2026, at 4:30 p.m. ET to discuss its financial results for the fiscal 2026 third quarter ended June 30, 2026.We"
},
{
"title": "Oligonucleotide CDMO Market to Reach USD 9.87 Billion by 2031 as RNA-Targeted Drug Pipelines Expand",
"url": "https://www.globenewswire.com/news-release/2026/07/15/3327496/28124/en/Oligonucleotide-CDMO-Market-to-Reach-USD-9-87-Billion-by-2031-as-RNA-Targeted-Drug-Pipelines-Expand.html",
"source": "GlobeNewswire Inc.",
"date": "2026-07-15T08:10:00Z",
"summary": "The global oligonucleotide contract development and manufacturing organization (CDMO) market is experiencing strong growth driven by expanding RNA-targeted medicine pipelines, increased outsourcing of complex synthesis and manufacturing, and rising demand for precision medicine. "
},
{
"title": "This Arrowhead Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday",
"url": "https://www.benzinga.com/analyst-stock-ratings/initiation/26/07/60437613/this-arrowhead-pharmaceuticals-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-tuesday",
"source": "Benzinga",
"date": "2026-07-14 07:46:10",
"summary": "Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page."
},
{
"title": "Ionis Pharmaceuticals Drops Another 9% as Bad News Piles Up",
"url": "https://finance.yahoo.com/healthcare/articles/ionis-pharmaceuticals-drops-another-9-193734273.html",
"source": "Yahoo! Finance",
"date": "2026-07-10T19:37:34Z",
"summary": "* IONS fell 21% this week after the Phase 3 eplontersen ATTR-CM trial missed its primary endpoint, with a monotherapy subgroup hinting at partial efficacy.\n\n* ALNY slipped 3.6% despite analysts flagging its Amvuttra as a direct beneficiary of eplontersen's miss, while BIIB bucked"
},
{
"title": "Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses Cardiometabolic Pipeline and Clinical Development Programs Transcript",
"url": "https://seekingalpha.com/article/4918575-arrowhead-pharmaceuticals-inc-arwr-discusses-cardiometabolic-pipeline-and-clinical",
"source": "Seeking Alpha",
"date": "2026-06-29 16:42:09",
"summary": "Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses Cardiometabolic Pipeline and Clinical Development Programs Transcript"
},
{
"title": "3 Under-the-Radar Biotech Takeover Targets for the Next Pharma Buying Spree",
"url": "https://247wallst.com/investing/2026/06/25/3-under-the-radar-biotech-takeover-targets-for-the-next-pharma-buying-spree/",
"source": "24/7 Wall Street",
"date": "2026-06-25 08:15:12",
"summary": "Large-cap pharma is back in the deal market. AbbVie's (NASDAQ: ABBV | ABBV Price Prediction) pending acquisition of Apogee Therapeutics signaled that big buyers will pay up for de-risked clinical assets."
},
{
"title": "Arrowhead Pharmaceuticals Receives Marketing Authorization in the European Union for REDEMPLO\u00ae (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)",
"url": "https://www.businesswire.com/news/home/20260622025442/en/Arrowhead-Pharmaceuticals-Receives-Marketing-Authorization-in-the-European-Union-for-REDEMPLO%C2%AE-plozasiran-to-Reduce-Triglycerides-in-Adults-with-Familial-Chylomicronemia-Syndrome-FCS/",
"source": "Business Wire",
"date": "2026-06-22 12:33:00",
"summary": "PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the European Commission (EC) has formally granted marketing authorization for REDEMPLO\u00ae (plozasiran), a small interfering RNA (siRNA) medicine, as an adjunct to diet t"
},
{
"title": "Complement Inhibitors Market Outlook Remains Strong During the Forecast Period (2026\u20132036) with Increasing Adoption of C5 and C3 Targeted Drugs | DelveInsight",
"url": "https://www.globenewswire.com/news-release/2026/04/30/3285292/0/en/Complement-Inhibitors-Market-Outlook-Remains-Strong-During-the-Forecast-Period-2026-2036-with-Increasing-Adoption-of-C5-and-C3-Targeted-Drugs-DelveInsight.html",
"source": "GlobeNewswire Inc.",
"date": "2026-04-30T17:00:00Z",
"summary": "The complement inhibitors market is projected to experience strong growth through 2036, driven by rising prevalence of complement-mediated diseases, increased R&D efforts, and approval of new therapeutic agents. The US represents the largest market, with IgAN showing approximatel"
},
{
"title": "IgA Nephropathy Market Forecast to 2036: Novel Therapies and Key Growth Drivers Fuel Expansion | DelveInsight",
"url": "https://www.globenewswire.com/news-release/2026/04/29/3284126/0/en/IgA-Nephropathy-Market-Forecast-to-2036-Novel-Therapies-and-Key-Growth-Drivers-Fuel-Expansion-DelveInsight.html",
"source": "GlobeNewswire Inc.",
"date": "2026-04-29T17:00:00Z",
"summary": "The IgA Nephropathy (IgAN) market is projected to grow at 18.6% CAGR through 2036, driven by rising disease prevalence, improved diagnostics, and a robust pipeline of novel immunotherapies. The market was valued at $1.5 billion in 2025, with recent FDA approvals including VOYXACT"
},
{
"title": "Meta, Moderna among market cap stock movers on Friday By Investing.com",
"url": "https://www.investing.com/news/stock-market-news/meta-moderna-among-market-cap-stock-movers-on-friday-93CH-4786652",
"source": "Investing.com",
"date": "2026-04-20T18:08:21Z",
"summary": "Friday's market has seen swings in various stocks based on news and other factors. Today, stocks like Facebook (META) are rallying, while Moderna (MRNA) is experiencing a decline. Below are highlights of some of the biggest stock movers, from mega-caps to small caps.\n\nMega-Cap Mo"
}
]
Data:
[
{
"symbol": "ARWR",
"date": "2026-08-04",
"epsActual": null,
"epsEstimated": -1.27667,
"revenueActual": null,
"revenueEstimated": 44172730,
"lastUpdated": "2026-07-30"
},
{
"symbol": "ARWR",
"date": "2026-05-07",
"epsActual": -0.93,
"epsEstimated": -1.09,
"revenueActual": 73737000,
"revenueEstimated": 73841700,
"lastUpdated": "2026-07-30"
},
{
"symbol": "ARWR",
"date": "2026-02-05",
"epsActual": 0.22,
"epsEstimated": 0.6,
"revenueActual": 264033000,
"revenueEstimated": 213941800,
"lastUpdated": "2026-05-05"
},
{
"symbol": "ARWR",
"date": "2025-11-25",
"epsActual": -0.18,
"epsEstimated": -0.11157,
"revenueActual": 256472000,
"revenueEstimated": 175316000,
"lastUpdated": "2026-02-25"
},
{
"symbol": "ARWR",
"date": "2025-08-07",
"epsActual": -1.26,
"epsEstimated": -0.94,
"revenueActual": 27767000,
"revenueEstimated": 154055700,
"lastUpdated": "2025-11-07"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "ARWR",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "ARWR",
"periods": [
{
"file_period": "202603b",
"settlement_date": "20260331",
"quantity_fails": 2,
"price": 57.65
},
{
"file_period": "202604a",
"settlement_date": "20260413",
"quantity_fails": 236,
"price": 65.14
},
{
"file_period": "202604b",
"settlement_date": "20260421",
"quantity_fails": 2726,
"price": 69.25
},
{
"file_period": "202606a",
"settlement_date": "20260612",
"quantity_fails": 7,
"price": 74.41
},
{
"file_period": "202606b",
"settlement_date": "20260630",
"quantity_fails": 239,
"price": 80.5
},
{
"file_period": "202607a",
"settlement_date": "20260708",
"quantity_fails": 28090,
"price": 86.97
}
],
"trend": "rising",
"trend_description": "FTD quantity increasing \u2014 settlement pressure building, potential squeeze precursor"
}
}
Data:
{
"insider": [
{
"symbol": "ARWR",
"filingDate": "2026-06-17",
"transactionDate": "2026-06-15",
"reportingCik": "0002141314",
"companyCik": "0000879407",
"transactionType": "A-Award",
"securitiesOwned": 11882,
"reportingName": "Cohen Matthew Gregory",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 11882,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000214131426000004/0002141314-26-000004-index.htm"
},
{
"symbol": "ARWR",
"filingDate": "2026-06-17",
"transactionDate": "2026-06-15",
"reportingCik": "0002141314",
"companyCik": "0000879407",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "Cohen Matthew Gregory",
"typeOfOwner": "director",
"acquisitionOrDisposition": "",
"directOrIndirect": "D",
"formType": "3",
"securitiesTransacted": 0,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000214131426000003/0002141314-26-000003-index.htm"
},
{
"symbol": "ARWR",
"filingDate": "2026-05-14",
"transactionDate": "2026-05-12",
"reportingCik": "0001767584",
"companyCik": "0000879407",
"transactionType": "S-Sale",
"securitiesOwned": 52012,
"reportingName": "Lu Hongbo",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2970,
"price": 76.88,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000176758426000002/0001767584-26-000002-index.htm"
},
{
"symbol": "ARWR",
"filingDate": "2026-04-24",
"transactionDate": "2026-04-22",
"reportingCik": "0002081169",
"companyCik": "0000879407",
"transactionType": "S-Sale",
"securitiesOwned": 172792,
"reportingName": "Apel Daniel Joseph",
"typeOfOwner": "officer: Chief Financial Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 3208,
"price": 70.11,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000087940726000039/0000879407-26-000039-index.htm"
},
{
"symbol": "ARWR",
"filingDate": "2026-04-24",
"transactionDate": "2026-04-22",
"reportingCik": "0002081169",
"companyCik": "0000879407",
"transactionType": "S-Sale",
"securitiesOwned": 171635,
"reportingName": "Apel Daniel Joseph",
"typeOfOwner": "officer: Chief Financial Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1157,
"price": 70.45,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000087940726000039/0000879407-26-000039-index.htm"
},
{
"symbol": "ARWR",
"filingDate": "2026-04-24",
"transactionDate": "2026-04-22",
"reportingCik": "0002081169",
"companyCik": "0000879407",
"transactionType": "S-Sale",
"securitiesOwned": 162905,
"reportingName": "Apel Daniel Joseph",
"typeOfOwner": "officer: Chief Financial Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 8730,
"price": 71.92,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000087940726000039/0000879407-26-000039-index.htm"
},
{
"symbol": "ARWR",
"filingDate": "2026-04-24",
"transactionDate": "2026-04-23",
"reportingCik": "0001830755",
"companyCik": "0000879407",
"transactionType": "S-Sale",
"securitiesOwned": 226958,
"reportingName": "Hamilton James C",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 10000,
"price": 75,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000183075526000007/0001830755-26-000007-index.htm"
},
{
"symbol": "ARWR",
"filingDate": "2026-03-09",
"transactionDate": "2026-03-05",
"reportingCik": "0001830755",
"companyCik": "0000879407",
"transactionType": "S-Sale",
"securitiesOwned": 236958,
"reportingName": "Hamilton James C",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 10000,
"price": 64.19,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/879407/000183075526000006/0001830755-26-000006-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
{
"symbol": "ARWR",
"senateID": "D000625",
"disclosureDate": "2023-02-24",
"transactionDate": "2023-01-31",
"firstName": "Daniel",
"lastName": "Goldman",
"office": "Daniel Goldman",
"district": "NY10",
"owner": "",
"assetDescription": "Arrowhead Pharmaceuticals Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20022407.pdf"
}
],
"dark_pool": [
{
"ticker": "ARWR",
"executed_at": "2026-07-29T21:01:39.345000Z",
"size": 23982.0,
"price": 86.22,
"premium": 2067728.04,
"volume": 23982.0,
"trade_code": " "
},
{
"ticker": "ARWR",
"executed_at": "2026-07-29T20:00:01.614000Z",
"size": 18300.0,
"price": 86.22,
"premium": 1577826.0,
"volume": 18300.0,
"trade_code": "6"
},
{
"ticker": "ARWR",
"executed_at": "2026-07-29T20:00:01.614000Z",
"size": 10296.0,
"price": 86.22,
"premium": 887721.12,
"volume": 10296.0,
"trade_code": "6"
},
{
"ticker": "ARWR",
"executed_at": "2026-07-29T20:00:01.614000Z",
"size": 5728.0,
"price": 86.22,
"premium": 493868.16,
"volume": 5728.0,
"trade_code": "6"
},
{
"ticker": "ARWR",
"executed_at": "2026-07-29T20:00:01.614000Z",
"size": 3623.0,
"price": 86.22,
"premium": 312375.06,
"volume": 3623.0,
"trade_code": "6"
},
{
"ticker": "ARWR",
"executed_at": "2026-07-29T20:00:35.118000Z",
"size": 2533.0,
"price": 86.22,
"premium": 218395.26,
"volume": 2533.0,
"trade_code": " "
},
{
"ticker": "ARWR",
"executed_at": "2026-07-29T20:00:34.929000Z",
"size": 1914.0,
"price": 86.22,
"premium": 165025.08,
"volume": 1914.0,
"trade_code": " "
},
{
"ticker": "ARWR",
"executed_at": "2026-07-29T20:00:34.933000Z",
"size": 1850.0,
"price": 86.22,
"premium": 159507.0,
"volume": 1850.0,
"trade_code": " "
}
],
"ats": {
"symbol": "ARWR",
"date": "20260729",
"ats_volume": 0,
"total_volume": 725091,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260729",
"ats_ratio": 0.0
},
{
"date": "20260728",
"ats_ratio": 0.0
},
{
"date": "20260727",
"ats_ratio": 0.0
},
{
"date": "20260724",
"ats_ratio": 0.0
},
{
"date": "20260723",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "ARWR",
"days": [
{
"date": "2026-07-29",
"close": 86.22,
"vwap": 86.01,
"volume": 1808776,
"vwap_discount_pct": -0.24
},
{
"date": "2026-07-28",
"close": 85.78,
"vwap": 84.45,
"volume": 1694969,
"vwap_discount_pct": -1.55
},
{
"date": "2026-07-27",
"close": 85.53,
"vwap": 86.39,
"volume": 2444316,
"vwap_discount_pct": 1.01
},
{
"date": "2026-07-24",
"close": 85.6,
"vwap": 85.93,
"volume": 1825246,
"vwap_discount_pct": 0.38
},
{
"date": "2026-07-23",
"close": 86.78,
"vwap": 87.36,
"volume": 2479807,
"vwap_discount_pct": 0.67
}
],
"avg_vwap_discount_pct": 0.05,
"signal": "Neutral"
},
"options_flow": [
{
"volume": 23,
"expiry": "2026-09-18",
"executed_at": "2026-07-29T18:56:29.520584Z",
"sector": "Healthcare",
"option_type": "call",
"size": 20,
"delta": "0.690365488580166",
"premium": "24800.00",
"implied_volatility": "0.648942895147335",
"nbbo_bid": "12.40",
"nbbo_ask": "13.30",
"open_interest": 2652,
"underlying_price": "87.155",
"option_chain_id": "ARWR260918C00080000",
"price": "12.40",
"strike": "80",
"underlying_symbol": "ARWR"
},
{
"volume": 120,
"expiry": "2026-09-18",
"executed_at": "2026-07-29T19:12:29.649398Z",
"sector": "Healthcare",
"option_type": "call",
"size": 20,
"delta": "0.609516245093818",
"premium": "19600.00",
"implied_volatility": "0.629579276342019",
"nbbo_bid": "9.50",
"nbbo_ask": "10.30",
"open_interest": 1044,
"underlying_price": "87.79",
"option_chain_id": "ARWR260918C00085000",
"price": "9.80",
"strike": "85",
"underlying_symbol": "ARWR"
},
{
"volume": 100,
"expiry": "2026-09-18",
"executed_at": "2026-07-29T19:12:12.848882Z",
"sector": "Healthcare",
"option_type": "call",
"size": 20,
"delta": "0.608327197322942",
"premium": "19400.00",
"implied_volatility": "0.625024068068034",
"nbbo_bid": "9.50",
"nbbo_ask": "10.30",
"open_interest": 1044,
"underlying_price": "87.72",
"option_chain_id": "ARWR260918C00085000",
"price": "9.70",
"strike": "85",
"underlying_symbol": "ARWR"
},
{
"volume": 80,
"expiry": "2026-09-18",
"executed_at": "2026-07-29T19:11:45.773643Z",
"sector": "Healthcare",
"option_type": "call",
"size": 15,
"delta": "0.60773982191482",
"premium": "14250.00",
"implied_volatility": "0.611558525664203",
"nbbo_bid": "9.50",
"nbbo_ask": "9.50",
"open_interest": 1044,
"underlying_price": "87.67",
"option_chain_id": "ARWR260918C00085000",
"price": "9.50",
"strike": "85",
"underlying_symbol": "ARWR"
}
],
"net_premium": {
"ticker": "ARWR",
"net_call_premium": "-101047.00",
"net_put_premium": "850.00",
"call_premium": "413860.00",
"put_premium": "3520.00",
"bullish_premium": "130164.00",
"bearish_premium": "232061.00",
"put_call_ratio": "0.02266666666666666667",
"iv_rank": "20.4182",
"implied_move_perc": "0.119000",
"gex_ratio": "0.66197401880839574866",
"gex_net_change": "-1308.3881",
"gex_call_delta": "1432903.5365",
"gex_put_delta": "-368519.1153",
"gex_date": "2026-07-30"
},
"hot_chains": [
{
"last_price": "3.31",
"option_symbol": "ARWR270115C00125000",
"open_interest": 35,
"volume": 273,
"ask_volume": 91,
"bid_volume": 160,
"nbbo_bid": "1.55",
"nbbo_ask": "5.40",
"avg_price": "3.3669230769230769230769230767"
},
{
"last_price": "9.80",
"option_symbol": "ARWR260918C00085000",
"open_interest": 1044,
"volume": 120,
"ask_volume": 20,
"bid_volume": 70,
"nbbo_bid": "8.40",
"nbbo_ask": "9.90",
"avg_price": "9.589583333333333333333333334"
},
{
"last_price": "2.55",
"option_symbol": "ARWR260821C00092500",
"open_interest": 163,
"volume": 104,
"ask_volume": 81,
"bid_volume": 22,
"nbbo_bid": "1.00",
"nbbo_ask": "4.30",
"avg_price": "2.7801923076923076923076923075"
},
{
"last_price": "4.21",
"option_symbol": "ARWR270115C00120000",
"open_interest": 315,
"volume": 92,
"ask_volume": 32,
"bid_volume": 42,
"nbbo_bid": "2.50",
"nbbo_ask": "5.20",
"avg_price": "4.3317391304347826086956521739"
},
{
"last_price": "6.51",
"option_symbol": "ARWR260918C00090000",
"open_interest": 2613,
"volume": 38,
"ask_volume": 24,
"bid_volume": 9,
"nbbo_bid": "6.10",
"nbbo_ask": "7.40",
"avg_price": "7.0702631578947368421052631579"
},
{
"last_price": "2.20",
"option_symbol": "ARWR260821C00095000",
"open_interest": 487,
"volume": 26,
"ask_volume": 2,
"bid_volume": 21,
"nbbo_bid": "1.40",
"nbbo_ask": "4.10",
"avg_price": "2.0611538461538461538461538461"
},
{
"last_price": "12.40",
"option_symbol": "ARWR260918C00080000",
"open_interest": 2652,
"volume": 23,
"ask_volume": 0,
"bid_volume": 23,
"nbbo_bid": "10.70",
"nbbo_ask": "13.40",
"avg_price": "12.301304347826086956521739131"
},
{
"last_price": "0.80",
"option_symbol": "ARWR260821C00105000",
"open_interest": 612,
"volume": 18,
"ask_volume": 3,
"bid_volume": 15,
"nbbo_bid": "0.25",
"nbbo_ask": "0.80",
"avg_price": "0.7338888888888888888888888889"
}
],
"oi_changes": {
"net_call_oi_change": 141,
"net_put_oi_change": 3,
"top": [
{
"strike": null,
"oi_change": 299,
"type": "call"
},
{
"strike": null,
"oi_change": -144,
"type": "call"
},
{
"strike": null,
"oi_change": -14,
"type": "call"
},
{
"strike": null,
"oi_change": 3,
"type": "put"
},
{
"strike": null,
"oi_change": 3,
"type": "put"
}
]
}
}
Data:
{
"vix": 18.58,
"sp500": 7413.18,
"fed_funds": 3.64,
"yield_curve_10y2y": 0.34,
"hy_spread": 2.79,
"treasury": {
"date": "2026-07-29",
"month1": 3.73,
"month2": 3.83,
"month3": 3.83,
"month6": 3.97,
"year1": 4.04,
"year2": 4.22,
"year3": 4.29,
"year5": 4.37,
"year7": 4.51,
"year10": 4.67,
"year20": 5.21,
"year30": 5.2
},
"events": [
{
"title": "Advance GDP q/q",
"currency": "USD",
"date": "2026-07-30",
"time_utc": "12:30",
"impact": "High",
"forecast": "2.1%",
"previous": "2.0%",
"actual": null,
"minutes_until": -38
},
{
"title": "Core PCE Price Index m/m",
"currency": "USD",
"date": "2026-07-30",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.2%",
"previous": "0.3%",
"actual": null,
"minutes_until": -38
}
]
}
Data:
{
"days": 42,
"patterns": [
{
"name": "VWAP Touch",
"count": 42,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 42,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 42,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 40,
"pct": 95
},
{
"name": "Woodie Pivot Touch",
"count": 39,
"pct": 93
},
{
"name": "Gap Fill",
"count": 32,
"pct": 76
},
{
"name": "PDH/PDL Touch",
"count": 32,
"pct": 76
},
{
"name": "Open Retracement",
"count": 28,
"pct": 67
},
{
"name": "Darvas Box",
"count": 25,
"pct": 60
},
{
"name": "High Vol Open",
"count": 9,
"pct": 21
},
{
"name": "Power Hour",
"count": 7,
"pct": 17
}
]
}